Menu

Lineage Cell Therapeutics, Inc. LCTX

Full chart Compare
Set alert

Price alert · LCTX

All alert types
1.02 USD +0.04 (+3.75%)

At closeNov 6, 2026, 4:02 PM EST

1.02 0.00 0.00%

After hours · Nov 6, 4:02 PM ET

0.9808 Day range 1.03
0.90 52-week range 1.96
YTD
-38.92%
1 year
-41.04%

Revenue & Expenses

Other Operating Income → Expenses: $699.00KIncome Tax Benefit → Expenses: $5.11MExpenses → Selling, General & Admin: $18.46MExpenses → Research & Development: $17.73MExpenses → Other Expenses: $46.87MGross Profit → Expenses: $13.71MRevenue → Gross Profit: $13.71MRevenue → Cost of Revenue: $845.00KNet Loss → Expenses: $63.53MOther Operating Income$699.00KIncome Tax Benefit$5.11MGross Profit$13.71MNet Loss$63.53MCost of Revenue$845.00KExpenses$83.06MSelling, General & Admin$18.46MResearch & Development$17.73MOther Expenses$46.87MRevenue$14.56M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

LCTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
14.56M9.50M8.95M14.70M4.34M
14.56M9.50M8.95M14.70M4.34M
146.00K334.00K671.00K728.00K1.43M
14.41M9.16M8.27M13.97M2.92M
51.03M30.64M33.01M36.49M52.13M
17.73M12.47M15.71M13.99M33.91M
18.46M18.17M17.30M22.51M18.21M
-36.62M-21.48M-24.73M-22.52M-49.21M
-5.28M0-1.80M541.00K0
-63.53M-18.61M-21.49M-26.27M-43.02M
-63.53M-18.61M-21.49M-26.27M-43.02M
-63.53M-18.61M-21.49M-26.27M-43.02M
-63.37M-18.58M-21.48M-26.35M-43.27M
166.00K27.00K7.00K-80.00K-251.00K
-0.28-0.09-0.12-0.15-0.26
-0.28-0.09-0.12-0.15-0.26
-0.28-0.09-0.12-0.15-0.26
-68.81M-18.61M-23.29M-25.73M-43.02M
-68.81M-18.61M-23.29M-25.73M-43.02M
230.12M200.19M172.66M169.79M164.50M
230.12M200.19M172.66M169.79M164.50M